| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |